MBOT Microbot Medical Inc

Price (delayed)

$7.7

Market cap

$54.73M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.32

Enterprise value

$37.47M

Highlights
Microbot Medical's debt has decreased by 15% YoY and by 9% from the previous quarter
Microbot Medical's EPS has increased by 14% YoY but it has decreased by 2.3% QoQ
MBOT's quick ratio is down by 44% YoY
MBOT's net income is down by 25% year-on-year

Key stats

What are the main financial stats of MBOT
Market
Shares outstanding
7.11M
Market cap
$54.73M
Enterprise value
$37.47M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.45
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$9.29M
EBITDA
-$9.22M
Free cash flow
-$3.35M
Per share
EPS
-$1.32
Free cash flow per share
-$0.47
Book value per share
$3.14
Revenue per share
$0
TBVPS
$3.4
Balance sheet
Total assets
$24.17M
Total liabilities
$1.84M
Debt
$738,000
Equity
$22.33M
Working capital
$21.93M
Liquidity
Debt to equity
0.03
Current ratio
18.2
Quick ratio
18.04
Net debt/EBITDA
1.87
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-34.5%
Return on equity
-36.9%
Return on invested capital
-255.3%
Return on capital employed
-40.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MBOT stock price

How has the Microbot Medical stock price performed over time
Intraday
-0.65%
1 week
1.58%
1 month
14.58%
1 year
11.27%
YTD
11.76%
QTD
-9.52%

Financial performance

How have Microbot Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$9.32M
Net income
-$9.35M
Gross margin
N/A
Net margin
N/A
MBOT's net income is down by 25% year-on-year
MBOT's operating income is down by 24% year-on-year and by 2.5% since the previous quarter

Growth

What is Microbot Medical's growth rate over time

Valuation

What is Microbot Medical stock price valuation
P/E
N/A
P/B
2.45
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Microbot Medical's EPS has increased by 14% YoY but it has decreased by 2.3% QoQ
The stock's price to book (P/B) is 52% less than its 5-year quarterly average of 5.1 but 17% more than its last 4 quarters average of 2.1
The equity has decreased by 25% YoY and by 8% QoQ

Efficiency

How efficient is Microbot Medical business performance
The company's return on invested capital has surged by 97% YoY and by 26% QoQ
The ROE has contracted by 9% from the previous quarter but it has grown by 7% YoY
MBOT's return on assets is down by 8% since the previous quarter and by 6% year-on-year

Dividends

What is MBOT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MBOT.

Financial health

How did Microbot Medical financials performed over time
MBOT's quick ratio is down by 44% YoY
The current ratio is down by 44% YoY and by 3.1% from the previous quarter
Microbot Medical's debt is 97% less than its equity
The equity has decreased by 25% YoY and by 8% QoQ
Microbot Medical's debt has decreased by 15% YoY and by 9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.